315 related articles for article (PubMed ID: 11753675)
1. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
Burke WM; Jin X; Lin HJ; Huang M; Liu R; Reynolds RK; Lin J
Oncogene; 2001 Nov; 20(55):7925-34. PubMed ID: 11753675
[TBL] [Abstract][Full Text] [Related]
2. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
Real PJ; Sierra A; De Juan A; Segovia JC; Lopez-Vega JM; Fernandez-Luna JL
Oncogene; 2002 Oct; 21(50):7611-8. PubMed ID: 12400004
[TBL] [Abstract][Full Text] [Related]
3. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
4. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.
Blaskovich MA; Sun J; Cantor A; Turkson J; Jove R; Sebti SM
Cancer Res; 2003 Mar; 63(6):1270-9. PubMed ID: 12649187
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
Alas S; Bonavida B
Clin Cancer Res; 2003 Jan; 9(1):316-26. PubMed ID: 12538484
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Janus kinase 2 by cisplatin in cancer cells.
Song H; Sondak VK; Barber DL; Reid TJ; Lin J
Int J Oncol; 2004 Apr; 24(4):1017-26. PubMed ID: 15010843
[TBL] [Abstract][Full Text] [Related]
8. A Ras homologue member I directly inhibits signal transducers and activators of transcription 3 translocation and activity in human breast and ovarian cancer cells.
Nishimoto A; Yu Y; Lu Z; Mao X; Ren Z; Watowich SS; Mills GB; Liao WS; Chen X; Bast RC; Luo RZ
Cancer Res; 2005 Aug; 65(15):6701-10. PubMed ID: 16061651
[TBL] [Abstract][Full Text] [Related]
9. Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells.
Huang HF; Murphy TF; Shu P; Barton AB; Barton BE
Mol Cancer; 2005 Jan; 4(1):2. PubMed ID: 15647107
[TBL] [Abstract][Full Text] [Related]
10. Cell-to-cell adhesion modulates Stat3 activity in normal and breast carcinoma cells.
Vultur A; Cao J; Arulanandam R; Turkson J; Jove R; Greer P; Craig A; Elliott B; Raptis L
Oncogene; 2004 Apr; 23(15):2600-16. PubMed ID: 15007380
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells.
Rahaman SO; Harbor PC; Chernova O; Barnett GH; Vogelbaum MA; Haque SJ
Oncogene; 2002 Dec; 21(55):8404-13. PubMed ID: 12466961
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.
Huang M; Page C; Reynolds RK; Lin J
Gynecol Oncol; 2000 Oct; 79(1):67-73. PubMed ID: 11006034
[TBL] [Abstract][Full Text] [Related]
13. Modulation of signal transducer and activator of transcription 3 activities by p53 tumor suppressor in breast cancer cells.
Lin J; Jin X; Rothman K; Lin HJ; Tang H; Burke W
Cancer Res; 2002 Jan; 62(2):376-80. PubMed ID: 11809683
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line.
Gariboldi MB; Ravizza R; Molteni R; Osella D; Gabano E; Monti E
Cancer Lett; 2007 Dec; 258(2):181-8. PubMed ID: 17920763
[TBL] [Abstract][Full Text] [Related]
15. Analysis of signal transducer and activator of transcription 3 (STAT3) in gastrointestinal stromal tumors.
Paner GP; Silberman S; Hartman G; Micetich KC; Aranha GV; Alkan S
Anticancer Res; 2003; 23(3B):2253-60. PubMed ID: 12894500
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma.
Aoki Y; Feldman GM; Tosato G
Blood; 2003 Feb; 101(4):1535-42. PubMed ID: 12393476
[TBL] [Abstract][Full Text] [Related]
17. Progestins induce transcriptional activation of signal transducer and activator of transcription 3 (Stat3) via a Jak- and Src-dependent mechanism in breast cancer cells.
Proietti C; Salatino M; Rosemblit C; Carnevale R; Pecci A; Kornblihtt AR; Molinolo AA; Frahm I; Charreau EH; Schillaci R; Elizalde PV
Mol Cell Biol; 2005 Jun; 25(12):4826-40. PubMed ID: 15923602
[TBL] [Abstract][Full Text] [Related]
18. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway.
Kanai M; Konda Y; Nakajima T; Izumi Y; Kanda N; Nanakin A; Kubohara Y; Chiba T
Oncogene; 2003 Jan; 22(4):548-54. PubMed ID: 12555068
[TBL] [Abstract][Full Text] [Related]
19. Blockade of constitutively activated Janus kinase/signal transducer and activator of transcription-3 pathway inhibits growth of human pancreatic cancer.
Toyonaga T; Nakano K; Nagano M; Zhao G; Yamaguchi K; Kuroki S; Eguchi T; Chijiiwa K; Tsuneyoshi M; Tanaka M
Cancer Lett; 2003 Nov; 201(1):107-16. PubMed ID: 14580692
[TBL] [Abstract][Full Text] [Related]
20. STAT3 mediates the survival signal in oncogenic ras-transfected intestinal epithelial cells.
Zushi S; Shinomura Y; Kiyohara T; Miyazaki Y; Kondo S; Sugimachi M; Higashimoto Y; Kanayama S; Matsuzawa Y
Int J Cancer; 1998 Oct; 78(3):326-30. PubMed ID: 9766567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
